Venus Remedies Ltd Share Price
(VENUSREM)
₹284.6
as on 12:53PM, 26 Mar 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -4.61 % |
3 Month Return | -4.91 % |
1 Year Return | -6.62 % |
Market Stats | |
Previous Close | ₹290.70 |
Open | ₹284.60 |
Volume | 45.75K |
Upper Circuit | ₹348.80 |
Lower Circuit | ₹232.60 |
Market Cap | ₹388.58Cr |
P/E Ratio
11.15
PEG Ratio
2.56
Market Cap
₹388.58 Cr
P/B Ratio
0.86
EPS
21.31
Dividend Yield
0Sector
Pharmaceuticals
ROE
6.18
Venus Remedies Secures Marketing Authorisation in Indonesia - 10 Feb, 2025
Venus Remedies Reports Strong Q3 Results, Hits Upper Circuit - 05 Feb, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 3 quarters, 1.22 Cr → 19.6 Cr (in ₹), with an average increase of 73.7% per quarter
Revenue Rich
Revenue is up for the last 3 quarters, 110.2 Cr → 188.8 Cr (in ₹), with an average increase of 21.9% per quarter
Retail Holding Up
Retail Investor have increased holdings from 56.91% to 57.13% in Dec 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 41.76% of holdings in Dec 2024 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.9% return, outperforming this stock by 134.5%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 72.2% return, outperforming this stock by 78.9%
Price Dip
In the last 3 months, VENUSREM stock has moved down by -4.9%
FII Holding Down
Foreign Institutions have decreased holdings from 1.18% to 1.11% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 41.76% | 0.00 | |
Foreign Institutions | 1.11% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 57.13% | 0.38 | |
Others | 0% |
Venus Remedies in the last 5 years
Lowest (-45.34x)
September 23, 2020
Today (11.15x)
March 25, 2025
Industry (54.31x)
March 25, 2025
Highest (21.70x)
December 28, 2023
Venus Remedies Ltd’s net profit jumped 186.13% since last year same period to ₹19.60Cr in the Q3 2024-2025. On a quarterly growth basis, Venus Remedies Ltd has generated 458.4% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Venus Remedies Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹388.58 Cr | 232.78% | 0.54 | ₹28 Cr | ₹601 Cr | |
NA | ₹4,992.12 Cr | 11.51% | 0.79 | -₹388 Cr | ₹75 Cr | |
NA | ₹104.00 Cr | -3.08% | 0.60 | NA | NA | |
NA | ₹71.57 Cr | 150.49% | 0.80 | NA | NA | |
NA | ₹276.72 Cr | 23.25% | 0.60 | ₹5 Cr | ₹173 Cr |
Organisation | Venus Remedies |
Headquarters | Panchkula |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Venus Remedies Ltd share price today stands at ₹284.6, Open: ₹284.6, Previous Close: ₹290.7, High: ₹296, Low: ₹284.15, 52 Week High: ₹427.9, 52 Week Low: ₹270.25.
Today's traded volume of Venus Remedies Ltd(VENUSREM) is 45.75K.
Today's market capitalisation of Venus Remedies Ltd(VENUSREM) is ₹388.58Cr.
Venus Remedies Ltd (VENUSREM) share price is ₹284.6. It is down -33.49% from its 52 Week High price of ₹427.9
Venus Remedies Ltd (VENUSREM) share price is ₹284.6. It is up 5.31% from its 52 Week Low price of ₹270.25